LIONHEAD(SH:600539) Zheng Quan Zhi Xing·2025-07-04 16:22Core Viewpoint - The company is in the process of issuing shares and paying cash to acquire 100% of Hangzhou Lipo Technology Co., Ltd. and is also raising supporting funds, with the transaction subject to various approvals and conditions [1][2][3]. Transaction Overview - The transaction consists of two parts: issuing shares and paying cash for asset acquisition, and raising supporting funds. The successful implementation of both is interdependent, meaning if one fails, the other will not proceed [2][5]. - The valuation and pricing of the transaction have not yet been determined, and it is expected to constitute a major asset restructuring as per relevant regulations [2][4]. - The funding subscribers for the supporting funds are companies controlled by the actual controller of the company, indicating that this transaction is a related party transaction [2][4]. Progress of the Transaction - The company's stock was suspended from trading starting February 24, 2025, with an expected suspension period of no more than 10 trading days [3]. - The company has been actively disclosing updates regarding the transaction, with several announcements made on April 8, May 8, and June 7, 2025, indicating that due diligence, auditing, and evaluation processes are ongoing [4][5]. - The company will continue to fulfill its information disclosure obligations in accordance with legal requirements as the transaction progresses [4][5].